Cergentis' Targeted Locus Amplification (TLA) Technology uniquely enables the targeted complete Next Generation Sequencing of any genomic locus in any genome of interest.

Biotechnology

Cergentis

Cergentis' headquarters in Utrecht, Netherlands

Erik Splinter

Marcel Gross

Bianca Reek

Sanne Vonk

Melinda Aprelia

Juan Jose Fernandez Palacio

Vera Boersma

Cheryl Dambrot

Dirk Pollet

Jan Groen

Wim Van Criekinge

Frank Grosveld

Sabine Linn

Han Brunner

Wouter De Laat

Maja Sanders

The Scientific and Technical Team at Cergentis leverages their expertise to advance and apply the company's Targeted Locus Amplification (TLA) Technology. Key activities include designing and conducting genomic experiments, developing bioinformatics tools to interpret complex genetic data, managing laboratory operations, and providing scientific support to ensure the accurate and efficient delivery of next-generation sequencing services.

Scientific and Technical Team

The Sales and Marketing Team at Cergentis focuses on driving revenue and market growth by promoting the company's Targeted Locus Amplification (TLA) Technology. They manage international sales efforts, develop and execute marketing strategies, create scientific content to engage and educate potential clients, and maintain strong relationships with key scientific accounts.

Sales and Marketing Team

The Quality Assurance team at Cergentis ensures that the Targeted Locus Amplification (TLA) Technology meets the highest standards of accuracy, reliability, and regulatory compliance. They develop, implement, and monitor quality control processes and conduct rigorous testing to maintain the integrity and consistency of genomic sequencing results.

Quality Assurance

Cergentis

Org chart

Board & advisors

Teams

Scientific and Technical Team

Sales and Marketing Team

Quality Assurance

Offices

Cergentis

Org chart

Board & advisors

Teams

Scientific and Technical Team

Sales and Marketing Team

Quality Assurance

Offices

Related companies